Title : A critical appraisal of MAO-B inhibitors in the treatment of Parkinson's disease.

Pub. Date : 2022 Jun

PMID : 35107654






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 For the MAO-B inhibitor safinamide, recently introduced to the market, an additional inhibition of pathological release of glutamate has been postulated. safinamide monoamine oxidase B Homo sapiens